The short version
Only one company currently supplies this market — there is no backup if it stumbles.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Tidl Pain Relief Evening Therapy Spray.
Pain Relief Evening Therapy Spray · MENTHOL 1 g/100mL; LIDOCAINE 4 g/100mL · Spray · Topical · Shenzhen Sam Technology Co., Ltd.
NDC 84214-0007-01 · 90 mL in 1 BOTTLE, SPRAY · OTC MONOGRAPH DRUG · View full market →
Medicare Part D
Medicare Part D does not cover over-the-counter drugs — by law it pays only for products requiring a prescription.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Regulatory
- Application
- M017
- TE code
- —
- Approval date
- —
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Pain Relief Evening Therapy Spray (Spray)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Shenzhen Sam Technology Co., Ltd. | MENTHOL 1 g/100mL; LIDOCAINE 4 g/100mL | Aug 26, 2026 | Sep 2, 2026 |
| Shenzhen Sam Technology Co., Ltd. | MENTHOL 4 g/100mL; LIDOCAINE 1 g/100mL | Jul 22, 2026 | Aug 19, 2026 |
| Shenzhen Sam Technology Co., Ltd. | LIDOCAINE 4 g/100mL; MENTHOL 1 g/100mL | Jul 15, 2026 | Jul 15, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Tidl Pain Relief Evening Therapy Spray. — NDC 84214-0007-01," retrieved September 3, 2026, https://drugdashboards.com/drug/84214000701.
Free to cite with attribution — see how the data is put together.